OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Parkinson’s disease and translational research
Elisabeth Dinter, Theodora Saridaki, Leonie Diederichs, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Elisabeth Dinter, Theodora Saridaki, Leonie Diederichs, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Showing 18 citing articles:
Iron toxicity, ferroptosis and microbiota in Parkinson’s disease: Implications for novel targets
Fernanda V. Carvalho, Harold E. Landis, Bruk Getachew, et al.
Advances in neurotoxicology (2024), pp. 105-132
Open Access | Times Cited: 9
Fernanda V. Carvalho, Harold E. Landis, Bruk Getachew, et al.
Advances in neurotoxicology (2024), pp. 105-132
Open Access | Times Cited: 9
Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 9
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 9
Novel Pharmacotherapies in Parkinson’s Disease
Yousef Tizabi, Bruk Getachew, Michael Aschner
Neurotoxicity Research (2021) Vol. 39, Iss. 4, pp. 1381-1390
Open Access | Times Cited: 34
Yousef Tizabi, Bruk Getachew, Michael Aschner
Neurotoxicity Research (2021) Vol. 39, Iss. 4, pp. 1381-1390
Open Access | Times Cited: 34
Silibinin ameliorates depression/anxiety-like behaviors of Parkinson's disease mouse model and is associated with attenuated STING-IRF3-IFN-β pathway activation and neuroinflammation
Xiumin Liu, Wenhui Chen, Chenkang Wang, et al.
Physiology & Behavior (2021) Vol. 241, pp. 113593-113593
Closed Access | Times Cited: 27
Xiumin Liu, Wenhui Chen, Chenkang Wang, et al.
Physiology & Behavior (2021) Vol. 241, pp. 113593-113593
Closed Access | Times Cited: 27
The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need
Shu Wang, Yin Jiang, Anchao Yang, et al.
Aging and Disease (2024)
Open Access | Times Cited: 4
Shu Wang, Yin Jiang, Anchao Yang, et al.
Aging and Disease (2024)
Open Access | Times Cited: 4
An artificial intelligence-based decision support system for early and accurate diagnosis of Parkinson’s Disease
Mahesh Thyluru Ramakrishna, V. Kumar, Rajat Bhardwaj, et al.
Decision Analytics Journal (2023) Vol. 10, pp. 100381-100381
Open Access | Times Cited: 10
Mahesh Thyluru Ramakrishna, V. Kumar, Rajat Bhardwaj, et al.
Decision Analytics Journal (2023) Vol. 10, pp. 100381-100381
Open Access | Times Cited: 10
Cell–Cell Communication Alterations via Intercellular Signaling Pathways in Substantia Nigra of Parkinson’s Disease
Maoxin Huang, Liang Xu, Jin Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 15
Maoxin Huang, Liang Xu, Jin Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 15
Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson’s Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus
Xiumin Liu, Chenkang Wang, Wei Wei Liu, et al.
Neurochemical Research (2021) Vol. 46, Iss. 9, pp. 2317-2332
Closed Access | Times Cited: 18
Xiumin Liu, Chenkang Wang, Wei Wei Liu, et al.
Neurochemical Research (2021) Vol. 46, Iss. 9, pp. 2317-2332
Closed Access | Times Cited: 18
Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo
Anne K. Braczynski, Marc Sevenich, Ian Gering, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 469-469
Open Access | Times Cited: 12
Anne K. Braczynski, Marc Sevenich, Ian Gering, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 469-469
Open Access | Times Cited: 12
Identification of cuproptosis-realated key genes and pathways in Parkinson’s disease via bioinformatics analysis
Jia Song, Jia Li, Xiaochen Pei, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299898-e0299898
Open Access | Times Cited: 1
Jia Song, Jia Li, Xiaochen Pei, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299898-e0299898
Open Access | Times Cited: 1
Novel Pharmacotherapies for L-DOPA-Induced Dyskinesia
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
Springer eBooks (2021), pp. 1-19
Closed Access | Times Cited: 5
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
Springer eBooks (2021), pp. 1-19
Closed Access | Times Cited: 5
Comparison of 18F-DOPA and 18F-DTBZ for PET/CT Imaging of Idiopathic Parkinson Disease
Xinchong Shi, Yang Yang, Lulu Jiang, et al.
Clinical Nuclear Medicine (2022) Vol. 47, Iss. 11, pp. 931-935
Closed Access | Times Cited: 3
Xinchong Shi, Yang Yang, Lulu Jiang, et al.
Clinical Nuclear Medicine (2022) Vol. 47, Iss. 11, pp. 931-935
Closed Access | Times Cited: 3
Novel Pharmacotherapies for L-DOPA-Induced Dyskinesia
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
Springer eBooks (2022), pp. 1637-1655
Closed Access | Times Cited: 3
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
Springer eBooks (2022), pp. 1637-1655
Closed Access | Times Cited: 3
Unraveling the interplay between dyskinesia and overactive bladder symptoms in Parkinson’s disease: a comprehensive cohort study based on the long-term follow-up database of Parkinson’s disease
Hong Jin, Yiheng Du, Jiahui Yan, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access
Hong Jin, Yiheng Du, Jiahui Yan, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access
Metabolic network connectivity disturbances in Parkinson's disease: a novel imaging biomarker
Bei Chen, Xiran Chen, Li‐Ling Peng, et al.
Cerebral Cortex (2024) Vol. 34, Iss. 9
Closed Access
Bei Chen, Xiran Chen, Li‐Ling Peng, et al.
Cerebral Cortex (2024) Vol. 34, Iss. 9
Closed Access
Sialorrhea in patients with Parkinson's disease: A case report
Marco Orsini, Isabella Paglione Pedrozo, Anna Luiza Guimarães Rosa, et al.
International Journal of Case Reports and Images (2022) Vol. 13, Iss. 2, pp. 1-4
Open Access
Marco Orsini, Isabella Paglione Pedrozo, Anna Luiza Guimarães Rosa, et al.
International Journal of Case Reports and Images (2022) Vol. 13, Iss. 2, pp. 1-4
Open Access
Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
Pedro Efraín Hernández-Arrambide, Alan Carrasco‐Carballo, Irving Parra, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 26, Iss. 3, pp. 230-239
Open Access
Pedro Efraín Hernández-Arrambide, Alan Carrasco‐Carballo, Irving Parra, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 26, Iss. 3, pp. 230-239
Open Access
Comparison of 18F-DOPA and 18F-DTBZ for PET/CT Imaging of Idiopathic Parkinson’s Disease
Xinchong Shi, Yang Yang, Lulu Jiang, et al.
Research Square (Research Square) (2021)
Open Access
Xinchong Shi, Yang Yang, Lulu Jiang, et al.
Research Square (Research Square) (2021)
Open Access
